Genetic profiling of healthy family members of breast and ovarian cancer patients in Estonia
The findings highlight the value of genetic testing in identifying at-risk individuals among HFMs of BCOC patients and the expansion of HFM testing in Estonia reflects increased public awareness and clinical integration of genetic risk assessment in cancer prevention strategies.